June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and tricuspid programs, presented as part of the late-breaking clinical trials at ...
EuroPCR
EuroPCR is the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and a world-leading course in interventional cardiovascular medicine. The event attracts more than 11,000 participants. Learn more about this conference at www.pcronline.com.
It is brutal and very expensive to bring a new transcatheter valve to market. Boston Scientific invested vast amounts of ...
June 7, 2021 — Edwards Lifesciences recently announced that clinical results from the company's transcatheter mitral and ...

May 26, 2021 — Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress for the updated ...
May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting ...
June 11, 2019 — Abbott recently announced positive late-breaking data from its TRILUMINATE study of the company's ...
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I ...
May 28, 2019 — Corindus Vascular Robotics Inc. announced its CorPath GRX System was successfully used to perform a live ...
May 28, 2019 — New data demonstrated that use of the investigational HeartFlow Planner, a real-time, non-invasive ...
May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical ...
May 22, 2019 — Edwards Lifesciences Corp. announced strategic clinical and regulatory milestones for its Edwards Pascal ...
May 20, 2019 — Philips announced the launch of the new IntraSight interventional applications platform. The secure ...
May 15, 2019 — Renal artery denervation (RDN) was found to be safe when employed with pulmonary vein isolation (PVI) to ...

May 10, 2019 — Here is the list of the late-breaking hot line studies being presented at the 2019 EuroPCR interventional ...
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and ...